Finch Therapeutics Group Inc
A biotech company that makes oral medicines built from beneficial gut microbes — known as microbiome therapeutics — to treat stubborn infections and inflammatory conditions. It was founded in 2014 by scientists who had earlier launched OpenBiome, a nonprofit stool bank, and its CEO turned to the field after a family member survived a serious C. diff infection that resisted standard treatment. The name honors Darwin's finches, a nod to how evolution shapes the tiny creatures living inside us.
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
8.01 Other Events
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · 8.01 Other Events
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
1.02 Termination of a Material Definitive Agreement